Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Wiedemann-Steiner syndrome is a rare genetic condition characterized by distinctive facial features, hairy elbows, short stature, and intellectual disability. This condition is caused by changes (mutations) in the KMT2A gene (also known as the MLL gene). It is inherited in an autosomal dominant manner. Most cases result from new (de novo) mutations that occur only in an egg or sperm cell, or just after conception. Treatment is symptomatic and supportive and may include special education classes and speech and occupational therapies aimed at increasing motor functioning and language.
Features include always present findings: Short stature, Postnatal growth retardation, Pes planus, and Intellectual disability and others; and very common findings: Depressed nasal tip, Downslanted palpebral fissures, Thick eyebrow, and Long eyelashes and others. 74 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Arms and legs | 10 | 2-3 toe syndactyly, Tapered finger, Prominent digit pad |
Brain and nerves | 7 | Seizure, Aggressive behavior, Depressed nasal tip |
Bones and joints | 5 | Delayed skeletal maturation, Joint hypermobility, Contracture of the distal interphalangeal joint of the fingers |
Growth and development | 4 | Short stature, Postnatal growth retardation, Failure to thrive |
Head and neck | 4 | Microcephaly, Flat face, Thin upper lip vermilion |
Eyes | 2 | Strabismus, Brow ptosis |
Muscles | 2 | Low muscle tone (hypotonia), Contracture of the distal interphalangeal joint of the fingers |
Digestive system | 2 | Constipation, Feeding difficulties |
Ears | 1 | Recurrent otitis media |
Heart and blood vessels | 1 | Atrial septal defect |
Wiedemann-Steiner syndrome (WSS) is characterized by developmental delay, intellectual disability, and characteristic facial features, with or without additional congenital anomalies. To date, more than 200 individuals have been reported in the medical literature with a pathogenic variant in KMT2A [, , , , , , , , , , , , , , , , , , , , , , , , , , , , ]. The following description of the phenotypic features associated with this condition is based on these reports.
Table 2.
Wiedemann-Steiner Syndrome: Frequency of Select Features
Feature | % of Persons w/Feature | Comment
Developmental delay /
| 97% |
| ~75% | Most typically thick eyebrows, long eyelashes, widely spaced eyes, narrow downslanted palpebral fissures
| ~63% |
Source: GeneReviews — "Wiedemann-Steiner Syndrome"
KMT2A encodes lysine methyltransferase 2A (3,969 aa). Histone methyltransferase that plays an essential role in early development and hematopoiesis. Highest expression in Brain Cerebellum (34.8 TPM) and Brain Cerebellar Hemisphere (32.5 TPM).
Wiedemann-Steiner syndrome is caused by mutations in the KMT2A gene on chromosome 11.
The KMT2A protein participates in p-S90-BMAL1:p-T451,T461-CLOCK,p-S-NPAS2:KMT2A:CRY1 gene pathway.
KMT2A is classified as a druggable target (Clinically Actionable, Druggable Genome, and Enzyme categories) with score 2.3.
No consensus clinical diagnostic criteria for Wiedemann-Steiner syndrome (WSS) have been published.
Wiedemann-Steiner syndrome should be suspected in individuals with the following clinical, imaging, and family history findings.
Clinical findings
Distinctive facial features (, , )
Hypertrichosis cubiti ("hairy elbows"), hypertrichosis of the back, and/or hypertrichosis of the lower limbs
Sacral dimple
Developmental delay/ intellectual disability
Hypotonia
Feeding difficulties
Failure to thrive
Short stature
Constipation
Imaging findings
Source: GeneReviews — "Wiedemann-Steiner Syndrome"
The features associated with Wiedemann-Steiner syndrome (WSS) overlap those of a wide range of disorders. summarizes those disorders most commonly considered in individuals with clinical findings consistent with WSS. For less commonly considered disorders in the differential diagnosis, refer to . Table 3. Key Disorders in the Differential Diagnosis of Wiedemann-Steiner Syndrome
Gene(s) | DiffDx Disorder | MOI | Clinical Features of DiffDx Disorder |
|---|---|---|---|
Coffin-Siris syndrome | AD | Syndromic short stature, hypertrichosis w/long eyelashes prominent eyebrows | Distal digit hypoplasia (usually 5th digit) BRAF KRAS LZTR1 MAP2K1 NRAS PTPN11 RAF1 RIT1 SOS1 |
Genetic testing for KMT2A is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for Wiedemann-Steiner syndrome. The disease remains an area of unmet medical need.
Suggested clinical practice guidelines for Wiedemann-Steiner syndrome (WSS) have been published. See (full text), (full text). Note: Institutional access or purchase required. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with WSS, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with Wiedemann-Steiner Syndrome
System/Concern | Evaluation | Comment |
|---|---|---|
Constitutional | Measurement of growth parameters | To identify those w/poor growth, incl those who have FTT those who may have growth hormone deficiency |
Neurologic | Neurologic eval | To incl brain MRI, as clinically indicated; Consider EEG if seizures are a concern in those who have a loss-of-function pathogenic KMT2A variant. |
Development | Developmental assessment | To incl motor, adaptive, cognitive, speech-language eval; Eval for early intervention/ special education Psychiatric/ |
Behavioral | Neuropsychiatric eval | Persons age 12 mos: screen for behavior concerns incl sleep disturbances, aggressive behaviors, /or traits suggestive of ASD. |
Musculoskeletal |
Source: GeneReviews — "Wiedemann-Steiner Syndrome"
1 trial found
Table 6.
Recommended Surveillance for Individuals with Wiedemann-Steiner Syndrome
System/Concern | Evaluation | Frequency
| • Measure growth parameters evaluate growth velocity.
Evaluate nutritional status.
| At each visit2
| Monitor for constipation.
| • Monitor those w/seizures as clinically indicated.1
Assess for new manifestations such as seizures.
Assess for clinical signs of medullar compression, esp in those w/vertebral anomalies.
| Monitor developmental progress educational needs.
Psychiatric/
| Behavior assessment for attention aggressive behaviors
| Physical medicine, OT/PT assessment of mobility, self-help skills
| Monitor for any signs/symptoms of arrhythmia.
| Monitor for any signs of frequent infection.
Family/
| Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources) care coordination.
| Monitor for signs/symptoms of sleep disturbance.
Dental eval | After eruption of primary teeth, every 6 mos
| Assessment for premature thelarche or pubertal abnormalities (primary amenorrhea) | Starting in childhood until growth/menarche is complete
Eyes | Ophthalmology eval | Annually or as clinically indicated
1. May include EEG follow up, as indicated
Source: GeneReviews — "Wiedemann-Steiner Syndrome"
Phenotype severity distribution: 11 always present features, 8 very common features, 30 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
32 publications have been identified in PubMed for Wiedemann-Steiner syndrome. Research spans Case Report / Case Series (56%), Review / Meta-Analysis (19%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 18 | 56% |
Research summaries | 6 | 19% |
Laboratory research | 5 | 16% |
Clinical study results | 2 | 6% |
Disease patterns and progression | 1 | 3% |
Hirai S (2026). [PMID: 41844570](https://pubmed.ncbi.nlm.nih.gov/41844570/). *Human genome variation*. [Case Report / Case Series]
Liang H (2026). [PMID: 41965552](https://pubmed.ncbi.nlm.nih.gov/41965552/). *BMC Endocr Disord*. [Case Report / Case Series]
Poulou M (2026). [PMID: 42196149](https://pubmed.ncbi.nlm.nih.gov/42196149/). *Int J Mol Sci*. [Review / Meta-Analysis]
Stacey G (2026). [PMID: 41518588](https://pubmed.ncbi.nlm.nih.gov/41518588/). *Journal of advanced nursing*. [Review / Meta-Analysis]
Manav Yiğit Z (2026). [PMID: 41320952](https://pubmed.ncbi.nlm.nih.gov/41320952/). *Balkan medical journal*. [Epidemiology / Natural History]
Stuiver S (2026). [PMID: 41557619](https://pubmed.ncbi.nlm.nih.gov/41557619/). *The journal of ECT*. [Case Report / Case Series]
Sokolova T (2026). [PMID: 41718288](https://pubmed.ncbi.nlm.nih.gov/41718288/). *Reports (MDPI)*. [Case Report / Case Series]
Ng R (2026). [PMID: 41137515](https://pubmed.ncbi.nlm.nih.gov/41137515/). *Clinical genetics*. [Basic Science / Preclinical]
Nishida H (2025). [PMID: 39840671](https://pubmed.ncbi.nlm.nih.gov/39840671/). *Pediatrics international : official journal of the Japan Pediatric Society*. [Case Report / Case Series]
Ng R (2025). [PMID: 40616444](https://pubmed.ncbi.nlm.nih.gov/40616444/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Data assembled from 9 of 12 sources · Last updated Sep 18, 2026, 8:56 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Wiedemann-Steiner syndrome
Noonan syndrome
ADAR1 |
Short stature, structural heart abnormalities, pulmonary hypertension, ocular abnormalities, hypotonia |
Higher frequency of congenital heart defects (50%-80%), pulmonary valve stenosis, absence of hypertrichosis BRD4 HDAC8 NIPBL RAD21 SMC1A SMC3 |
Cornelia de Lange syndrome | ADXL2 | Hypertrichosis, short stature, growth failure, DD/ID, ophthalmologic abnormalities, recurrent infections | Limb involvement, upper-extremity deficiencies ranging from severe reduction defects w/complete absence of forearms to various forms of oligodactyly CREBBP EP300 |
Rubinstein-Taybi Syndrome | AD | Short stature, DD/ID, hypertrichosis, congenital heart disease | Hyperinsulinism, grimacing/typical smile KDM6A KMT2D |
Kabuki syndrome | ADXL3 | Hypertrichosis, short stature, growth deficiency, DD/ID, multiple congenital anomalies | Hyperinsulinism |
TASP1 | Suleiman-El-Hattab syndrome (OMIM 618950) | AR | DD, hypotonia, microcephaly, feeding difficulties w/FTT, recurrent respiratory infections, cardiovascular malformations, happy demeanor, distinctive facial features4 |
Source: GeneReviews — "Wiedemann-Steiner Syndrome"
To inform mgmt Orthopedics / physical medicine rehab/ PT OT eval |
Feeding | Gastroenterology / nutrition/ feeding team eval | To incl eval of nutritional status; Consider eval for gastrostomy tube placement in those w/FTT. Evaluate for signs/symptoms of constipation. |
Eyes | Ophthalmologic eval | For diagnosis treatment of strabismus, blepharoptosis, refractive disorders, other rare eye complications |
ENT/Mouth | Consider sleep study. | Assess for sleep apnea Pediatric dentistry eval in those age 1 yr |
Cardiovascular | Echocardiogram EKG | To evaluate for congenital heart defects to screen for arrhythmia |
Genitourinary | Abdominal ultrasound | To assess for renal bladder abnormalities Consider external pelvic ultrasound in female neonates or in females of pubertal age or older.1 |
Integument | Dermatologic eval | If desired by family to assist in mgmt of hypertrichosis |
Endocrine | Endocrinology eval | To assess for short stature, growth hormone deficiency, hypothyroidism, metabolic bone disease; May consist of blood tests as well as radiographs (e.g., bone age x-rays) depending on clinical context |
Immunologic | Immunologic eval | To assess for immunodeficiency vaccine response; May incl quantitative immunoglobulins, vaccine titers, lymphocyte profile Genetic |
counseling | By genetics professionals2 | To inform affected persons their families re nature, MOI, implications of WSS to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with Wiedemann-Steiner Syndrome Manifestation/Concern | Treatment | Considerations/Other |
Epilepsy | Standardized treatment w/ASM by experienced neurologist or epileptologist | Many ASMs may be effective; none has been demonstrated effective specifically for this disorder.; Education of parents/caregivers1 Developmental delay/ Intellectual disability/ Behavioral issues |